JENNIFER WAGNER: Open Payments
NPI 1346459591 · NYACK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,454 in 72 payments from 16 companies in 2025. Trend: 2023 $1,339 · 2024 $1,414 · 2025 $1,454
Food & beverage: $1,374Education: $80
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 29 | $526 |
| ABBVIE INC. | 10 | $208 |
| GlaxoSmithKline, LLC. | 10 | $205 |
| Janssen Biotech, Inc. | 3 | $113 |
| PFIZER INC. | 5 | $103 |
| Merck Sharp & Dohme LLC | 3 | $57 |
| ARRAY BIOPHARMA INC | 2 | $35 |
| Gilead Sciences, Inc. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $34 |
| Daiichi Sankyo Inc. | 1 | $29 |
Products named: KISQALI, Fabhalta, EPKINLY, OJJAARA, RYBREVANT, LEQVIO, JEMPERLI, KEYTRUDA.
Industry payments across NY — which companies pay providers there.
